| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |